IDO1 and triple-A syndrome: Several IDO inhibitors which fulfill a function in Tryptophan, such as Indoximod, Epacadostat, and Navoximod, have been approved for patients in anti-tumor therapy182, but there is a lack of research to assess the application of these drugs on AAA.